Concepedia

Jamie B. Miyamoto

JB

Statistics

Publications

20

Citations

2.2K

H-Index

18

Active since

2007

Affiliations

Seagen (United States)(Current)

Jamie B. Miyamoto is an author at Seagen (United States) specializing in antibody-drug conjugates, antibody conjugates, and pharmacology.

Publications per year

2007–2020

20

Publications

20

Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate

Nicole M. Okeley, Jamie B. Miyamoto, Xinqun Zhang et al. · Clinical Cancer Research · 2010 · 387 citations · Full text

, , +17

Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models

Li Fu, Kim K. Emmerton, Mechthild Jonas et al. · Cancer Research · 2016 · 321 citations

, , +17

A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology

Scott C. Jeffrey, Patrick Burke, Robert P. Lyon et al. · Bioconjugate Chemistry · 2013 · 246 citations

, , +17

Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate

Svetlana O. Doronina, Tim D. Bovee, David W. Meyer et al. · Bioconjugate Chemistry · 2008 · 176 citations

, , +17

Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates

Patrick Burke, Joseph Z. Hamilton, Scott C. Jeffrey et al. · Molecular Cancer Therapeutics · 2016 · 150 citations

, , +17

1–5 of 20